https://thehill.com/policy/healthcare/538092-asthma-drug-reduces-hospitalization-for-covid-19-study
Quote:
The findings from 146 people of whom half took 800 micrograms of the medication twice a day and half were on usual care suggests that inhaled budesonide reduced the relative risk of requiring urgent care or hospitalisation by 90% in the 28-day study period. Participants allocated the budesonide inhaler also had a quicker resolution of fever, symptoms and fewer persistent symptoms after 28 days.
